• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

information for practice

news, new scholarship & more from around the world


advanced search
  • gary.holden@nyu.edu
  • @ Info4Practice
  • Archive
  • About
  • Help
  • Browse Key Journals
  • RSS Feeds

A record-linkage study of drug-related death and suicide after hospital discharge among drug-treatment clients in Scotland, 1996-2006

Abstract

Aims

To investigate the relationship between time after hospital discharge and drug-related death (DRD) and suicide among drug users in Scotland, while controlling for potential confounders.

Design

Cohort study

Setting and participants

The 69,457 individuals who registered for drug treatment in Scotland during 1 April 1996 to 31 March 2006.

Measurements

Time-at-risk was from the date of an individual’s first attendance at drug treatment services after 1 April 1996 until the earlier of date of death or end-of-study, 31 March 2006; and was categorized according to time since most recent hospitalization, as: during hospitalisation, within 28 days, 29-90 days, 91 days to 1 year, >1 year since discharge from most recent hospital stay versus ‘never admitted’ (reference).

Findings

Time-periods soon after discharge were associated with increased risk of DRD. DRD-rates per 1,000 person-years were: 87 (95% CI: 72-104) during hospitalisation, 21 (18-25) within 28 days, 12 (10-15) during 29-90 days and 8.5 (7.5-9.5) during 91 days to 1 year after discharge versus 4.2 (3.7-4.7) when > 1 year after most recent hospitalization and 1.9 (1.7-2.1) for those never admitted. Adjusted hazard ratios by time since hospital discharge (versus never admitted) were: 9.6 (95% CI: 8-12) within 28 days, 5.6 (4.6-6.8) during days 29-90, thereafter 4.0 (3.5-4.7) and 2.3 (2.0-2.7) when > 1 year. Non-drug-related suicides were less frequent than DRDs (269 versus 1383) but a similar risk-pattern was observed.

Conclusions

In people receiving treatment for drug dependence, discharge from a period of hospitalisation marks the start of a period of heightened vulnerability to drug-related death.

Posted in: Journal Article Abstracts on 08/24/2012 | Link to this post on IFP |
Share

Primary Sidebar

Categories

Category RSS Feeds

  • Calls & Consultations
  • Clinical Trials
  • Funding
  • Grey Literature
  • Guidelines Plus
  • History
  • Infographics
  • Journal Article Abstracts
  • Meta-analyses - Systematic Reviews
  • Monographs & Edited Collections
  • News
  • Open Access Journal Articles
  • Podcasts
  • Video

© 1993-2026 Dr. Gary Holden. All rights reserved.

gary.holden@nyu.edu
@Info4Practice